Home > Product > Peptide Pools > Antigens from Infectious Diseases > EBV (LMP2)

Antigens from Infectious Diseases

EBV (LMP2)

[Price Inquiry]
CAT#
PPO-H021
Size
1 vial containing 15 nmol ( 25μg) per peptide
Purity
>70% (HPLC-MS)
Format
Freeze dried in amber type glass vial
Application
T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Topics
Infection, Cancer, Hodgkin's lymphoma, Burkitt's lymphoma, Nasopharyngeal carcinoma, Dermatomyositis, Systemic lupus erythematosus, Rheumatoid arthritis, Sj?gren's syndrome, Multiple sclerosis
Number of peptides
122
Organism
Epstein-Barr virus (HHV-4)
Specifications
Peptide scan (15mers with 11 aa overlap)
Protein Length
497
Protein Name
Latent membrane protein 2 (LMP2)
Swiss-Prot ID
P13285
References
1."T-cell Therapy for EBV-Associated Nasopharyngeal Carcinoma: Preparative Lymphodepleting Chemotherapy Does not Improve Clinical Results". Secondino et al., Ann. Onc. (2012)
2."Expansion of T Cells Targeting Multiple Antigens of Cytomegalovirus, Epstein – Barr Virus and Adenovirus to Provide Broad Antiviral Specificity After Stem Cell Transplantation". Hanley et al., Cytotherapy (2011)
Home | Site Map | Contact Us | Resources
Copyright © 2008 - Creative Peptides. All rights reserved.